- Home
- CLDX vs FBP Comparison
CLDX vs FBP Comparison
Compare CLDX & FBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLDX | FBP |
|---|---|---|
| Founded | N/A | 1948 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 3.1B |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLDX | FBP |
|---|---|---|
| Price | $26.68 | $21.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $44.10 | $23.67 |
| AVG Volume (30 Days) | 757.1K | ★ 1.4M |
| Earning Date | 11-10-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 3.38% |
| EPS Growth | N/A | ★ 13.12 |
| EPS | N/A | ★ 2.05 |
| Revenue | $2,599,000.00 | ★ $902,789,000.00 |
| Revenue This Year | N/A | $12.49 |
| Revenue Next Year | $19.70 | $4.57 |
| P/E Ratio | ★ N/A | $10.40 |
| Revenue Growth | N/A | ★ 3.91 |
| 52 Week Low | $14.40 | $16.40 |
| 52 Week High | $30.50 | $22.61 |
Technical Indicators
Market Signals| Indicator | CLDX | FBP |
|---|---|---|
| Relative Strength Index (RSI) | 50.24 | 59.07 |
| Support Level | $24.97 | $21.20 |
| Resistance Level | $27.92 | $21.97 |
| Average True Range (ATR) | 1.21 | 0.44 |
| MACD | -0.20 | 0.06 |
| Stochastic Oscillator | 32.54 | 66.50 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.